Steward Health Care Chairman and CEO Ralph de la Torre, MD, has "amicably separated" from the system, effective Oct. 1, a Steward spokesperson confirmed to Becker's .

Biopharmaceutical company Cassava Sciences, along with founder Remi Barbier and former Senior Vice President of Neuroscience Lindsay Burns, PhD, will pay more than $40 million to settle allegations ...

New North Carolina law requires hospitals to have armed law enforcement officers in emergency departments starting Oct. 1, in response to growing violence ...

The Wisconsin Department of Health Services has denied the sale of three nonprofit SSM Health nursing facilities to a New Jersey-based for-profit company, the Wisconsin State Journal reported Sept. 27 ...

CEO Dr. Jawad Shah has grown Insight Health System from a small physician office into a multistate hospital system.

Norfolk, Va.-based Sentara Health is cutting about 200 positions, with a majority of the cuts coming from its health plan division.

Rockledge, Fla.-based Health First will transfer ownership of its Health First Cancer Institute building to Titusville, Fla.-based Parrish Healthcare as part of the health systems' collaboration.

The FDA has approved Cobenfy capsules from Bristol-Myers Squibb for the oral treatment of schizophrenia in adults. The medication, formerly known as KarXT, is the first antipsychotic medication to ...

In the wake of 2023 walkouts by pharmacy workers dubbed "pharmageddon," major chains such as Walgreens and CVS are facing increased pressure from their employees to provide better working conditions ...

Boston-based Dana-Farber Cancer Institute will lead 12 other health systems and academic institutions across the U.S. in a new cancer consortium aimed at addressing health equity and survival rates ...

Monique Díaz, MD, will assume the role of vice president and regional chief medical information officer for CommonSpirit Health's California region, according to her LinkedIn.

The phase 3 Tempo-1 trial for tavapadon, a dopamine receptor partial agonist, demonstrated significant efficacy as a monotherapy in early Parkinson's disease. Patients receiving the drug at doses of 5 ...